In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 5th, 2008 | 27 | Yes |
Popular Name: Quetiapine Quetiapine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 111974-69-7 , 111974-72-2 , 1287376-15-1 , [111974-69-7] , [111974-72-2]
111974-69-7; D08456; Norsic (TN); Quetiapine (INN)
111974-72-2; D00458; Quetiapine fumarate (JP16/USAN); Seroquel (TN)
2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol
2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol
2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol fumarate (2:1) (salt)
2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol hemifumarate
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol; Quetiapine
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-piperazin-1-yl)-ethoxy]-ethanol
2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol
2-{2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy}ethanol
2-{[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol
CPD000466273; SAM001247041; Seroquel
CPD000471623; QUETIAPINE HEMIFUMARATE
CPD000471623; QUETIAPINE HEMIFUMARATE; Quetiapine fumarate; SAM001246777
CPD000471623; QUETIAPINE HEMIFUMARATE; SAM001246777
Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-
Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-
ICI-204636, ZD 5077, ZM 204636, Seroquel XR
ICI-204636; ZD-5077; ZM-204636
INN); Quetiapine Fumarate (FDA
quetiapina; quetiapine; quetiapinum
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.49 | 6.32 | -12.1 | 1 | 5 | 0 | 49 | 383.517 | 6 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
mechanism | . | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 4.03e-02 g/l | DrugBank-approved |
mechanism | Antagonist of dopamine and serotonin receptors | IBScreen Bioactives IBScreen Bioactives |
biological_use | Antipsychotic and neuroleptic agent | ZereneX Building Blocks |
Indications | antipsychotic, schizophrenia, bipolar disorder | KeyOrganics Bioactives |
Therapy | antipsychotic: 5HT antagonist, dopamine antagonist, H1-antihistamine, alpha adrenergic blocker | SMDC Iconix |
Target | Dopamine Receptor | Selleck Chemicals |
Patent Database Links | EP1547650; EP1602650; EP1621198; EP1627639; EP1690858; EP1712225; EP1726952; EP1795199; EP1815854; EP1844769; EP1879027; EP1884243; EP1958617; EP1970055; EP1990639; US2005020571; US2005070552; US2006135511; US2006148790; US2006166974; US2006199798; US2006 | ChEBI |
Patent Database Links | EP1627639; EP1829534; EP1985287; US2005020571; US2006276641; US2007212428; US2007264358; WO2006081347; WO2006117700 | ChEBI |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP01075q; 1 fumaric acid | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 100656; .5 fumaric acid | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP01075q; SALT: 1 fumaric acid | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 100656; SALT: .5 fumaric acid | NIH Clinical Collection via PubChem |
mechanism | Specifically the D1 and D2 dopamine, the alpha 1 adrenoreceptor and alpha 2 adrenoreceptor, and 5-HT1A and 5-HT2 serotonin receptor | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT1A-1-E | Serotonin 1a (5-HT1a) Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 230 | 0.34 | Binding ≤ 10μM |
5HT2A-1-E | Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 82 | 0.37 | Binding ≤ 10μM |
5HT2B-1-E | Serotonin 2b (5-HT2b) Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 220 | 0.35 | Binding ≤ 10μM |
5HT2C-1-E | Serotonin 2c (5-HT2c) Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3820 | 0.28 | Binding ≤ 10μM |
5HT6R-2-E | Serotonin 6 (5-HT6) Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1400 | 0.30 | Binding ≤ 10μM |
ACM1-1-E | Muscarinic Acetylcholine Receptor M1 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 56 | 0.38 | Binding ≤ 10μM |
ACM2-4-E | Muscarinic Acetylcholine Receptor M2 (cluster #4 Of 6), Eukaryotic | Eukaryotes | 1020 | 0.31 | Binding ≤ 10μM |
ACM3-1-E | Muscarinic Acetylcholine Receptor M3 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1020 | 0.31 | Binding ≤ 10μM |
ACM4-1-E | Muscarinic Acetylcholine Receptor M4 (cluster #1 Of 6), Eukaryotic | Eukaryotes | 1020 | 0.31 | Binding ≤ 10μM |
ACM5-3-E | Muscarinic Acetylcholine Receptor M5 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 1020 | 0.31 | Binding ≤ 10μM |
ADA1A-1-E | Alpha-1a Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 58 | 0.38 | Binding ≤ 10μM |
ADA1B-1-E | Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 58 | 0.38 | Binding ≤ 10μM |
ADA1D-1-E | Alpha-1d Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 58 | 0.38 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 87 | 0.37 | Binding ≤ 10μM |
ADA2B-1-E | Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 87 | 0.37 | Binding ≤ 10μM |
ADA2C-1-E | Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 87 | 0.37 | Binding ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 4240 | 0.28 | Binding ≤ 10μM |
DRD3-1-E | Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 650 | 0.32 | Binding ≤ 10μM |
DRD4-2-E | Dopamine D4 Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 2200 | 0.29 | Binding ≤ 10μM |
HRH1-1-E | Histamine H1 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 9 | 0.42 | Binding ≤ 10μM |
KCNH2-2-E | HERG (cluster #2 Of 5), Eukaryotic | Eukaryotes | 5754 | 0.27 | Binding ≤ 10μM |
Q63380-1-E | Transporter (cluster #1 Of 1), Eukaryotic | Eukaryotes | 680 | 0.32 | Binding ≤ 10μM |
DRD2-4-E | Dopamine D2 Receptor (cluster #4 Of 24), Eukaryotic | Eukaryotes | 330 | 0.34 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 4.5 | 0.43 | Binding ≤ 1μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 4.5 | 0.43 | Binding ≤ 1μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 4.5 | 0.43 | Binding ≤ 1μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 87 | 0.37 | Binding ≤ 1μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 87 | 0.37 | Binding ≤ 1μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 87 | 0.37 | Binding ≤ 1μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 390 | 0.33 | Binding ≤ 1μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 180 | 0.35 | Binding ≤ 1μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 180 | 0.35 | Binding ≤ 1μM |
DRD3_HUMAN | P35462 | Dopamine D3 Receptor, Human | 320 | 0.34 | Binding ≤ 1μM |
HRH1_RAT | P31390 | Histamine H1 Receptor, Rat | 40 | 0.38 | Binding ≤ 1μM |
HRH1_HUMAN | P35367 | Histamine H1 Receptor, Human | 19 | 0.40 | Binding ≤ 1μM |
ACM1_HUMAN | P11229 | Muscarinic Acetylcholine Receptor M1, Human | 100 | 0.36 | Binding ≤ 1μM |
5HT1A_HUMAN | P08908 | Serotonin 1a (5-HT1a) Receptor, Human | 230 | 0.34 | Binding ≤ 1μM |
5HT1A_RAT | P19327 | Serotonin 1a (5-HT1a) Receptor, Rat | 230 | 0.34 | Binding ≤ 1μM |
5HT2A_HUMAN | P28223 | Serotonin 2a (5-HT2a) Receptor, Human | 120 | 0.36 | Binding ≤ 1μM |
5HT2A_RAT | P14842 | Serotonin 2a (5-HT2a) Receptor, Rat | 220 | 0.35 | Binding ≤ 1μM |
5HT2B_HUMAN | P41595 | Serotonin 2b (5-HT2b) Receptor, Human | 220 | 0.35 | Binding ≤ 1μM |
5HT2C_HUMAN | P28335 | Serotonin 2c (5-HT2c) Receptor, Human | 220 | 0.35 | Binding ≤ 1μM |
Q63380_RAT | Q63380 | Transporter, Rat | 680 | 0.32 | Binding ≤ 1μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 4.5 | 0.43 | Binding ≤ 10μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 4.5 | 0.43 | Binding ≤ 10μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 4.5 | 0.43 | Binding ≤ 10μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 1100 | 0.31 | Binding ≤ 10μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 1100 | 0.31 | Binding ≤ 10μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 1100 | 0.31 | Binding ≤ 10μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 1300 | 0.31 | Binding ≤ 10μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 180 | 0.35 | Binding ≤ 10μM |
DRD2_RAT | P61169 | Dopamine D2 Receptor, Rat | 180 | 0.35 | Binding ≤ 10μM |
DRD3_HUMAN | P35462 | Dopamine D3 Receptor, Human | 320 | 0.34 | Binding ≤ 10μM |
DRD4_HUMAN | P21917 | Dopamine D4 Receptor, Human | 1600 | 0.30 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 5754.39937 | 0.27 | Binding ≤ 10μM |
HRH1_RAT | P31390 | Histamine H1 Receptor, Rat | 40 | 0.38 | Binding ≤ 10μM |
HRH1_HUMAN | P35367 | Histamine H1 Receptor, Human | 19 | 0.40 | Binding ≤ 10μM |
ACM1_HUMAN | P11229 | Muscarinic Acetylcholine Receptor M1, Human | 100 | 0.36 | Binding ≤ 10μM |
ACM2_HUMAN | P08172 | Muscarinic Acetylcholine Receptor M2, Human | 1020 | 0.31 | Binding ≤ 10μM |
ACM3_HUMAN | P20309 | Muscarinic Acetylcholine Receptor M3, Human | 1020 | 0.31 | Binding ≤ 10μM |
ACM4_HUMAN | P08173 | Muscarinic Acetylcholine Receptor M4, Human | 1020 | 0.31 | Binding ≤ 10μM |
ACM5_HUMAN | P08912 | Muscarinic Acetylcholine Receptor M5, Human | 1020 | 0.31 | Binding ≤ 10μM |
5HT1A_HUMAN | P08908 | Serotonin 1a (5-HT1a) Receptor, Human | 230 | 0.34 | Binding ≤ 10μM |
5HT1A_RAT | P19327 | Serotonin 1a (5-HT1a) Receptor, Rat | 230 | 0.34 | Binding ≤ 10μM |
5HT2A_RAT | P14842 | Serotonin 2a (5-HT2a) Receptor, Rat | 220 | 0.35 | Binding ≤ 10μM |
5HT2A_HUMAN | P28223 | Serotonin 2a (5-HT2a) Receptor, Human | 120 | 0.36 | Binding ≤ 10μM |
5HT2B_HUMAN | P41595 | Serotonin 2b (5-HT2b) Receptor, Human | 220 | 0.35 | Binding ≤ 10μM |
5HT2C_HUMAN | P28335 | Serotonin 2c (5-HT2c) Receptor, Human | 1400 | 0.30 | Binding ≤ 10μM |
5HT6R_HUMAN | P50406 | Serotonin 6 (5-HT6) Receptor, Human | 1400 | 0.30 | Binding ≤ 10μM |
Q63380_RAT | Q63380 | Transporter, Rat | 680 | 0.32 | Binding ≤ 10μM |
Description | Species |
---|---|
Acetylcholine regulates insulin secretion | |
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
Dopamine receptors | |
G alpha (12/13) signalling events | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (s) signalling events | |
G alpha (z) signalling events | |
Histamine receptors | |
Muscarinic acetylcholine receptors | |
Serotonin receptors | |
Voltage gated Potassium channels |